Effects of quercetin and EGCG on mitochondrial biogenesis and immunity

Med Sci Sports Exerc. 2009 Jul;41(7):1467-75. doi: 10.1249/MSS.0b013e318199491f.

Abstract

Purpose: To test the influence of 1000 mg of quercetin (Q) with or without 120 mg of epigallocatechin 3-gallate (EGCG), 400 mg of isoquercetin, and 400 mg of eicosapentaenoic acid and docosahexaenoic acid (Q-EGCG) on exercise performance, muscle mitochondrial biogenesis, and changes in measures of immunity and inflammation before and after a 3-d period of heavy exertion.

Methods: Trained cyclists (N = 39) were randomized to placebo (P), Q, or Q-EGCG and ingested supplements in a double-blinded fashion for 2 wk before, during, and 1 wk after a 3-d period in which subjects cycled for 3 h x d(-1) at approximately 57% Wmax. Blood, saliva, and muscle biopsy samples were collected before and after 2 wk of supplementation and immediately after the exercise bout on the third day. Blood and saliva samples were also collected 14 h after exercise.

Results: Two-week supplementation resulted in a significant increase in plasma quercetin for Q and Q-EGCG and granulocyte oxidative burst activity (GOBA) in Q-EGCG. Immediately after the third exercise bout, significant decreases for C-reactive protein (CRP), and plasma interleukin 6 (IL-6) and interleukin 10 (IL-10) were measured in Q-EGCG compared with P. Granulocyte colony-stimulating factor and CRP were reduced in Q-EGCG 14 h after exercise. No group differences were measured in muscle messenger RNA expression for peroxisome proliferator-activated receptor gamma coactivator alpha, citrate synthase, or cytochrome c.

Conclusions: Two-week supplementation with Q-EGCG was effective in augmenting GOBA andin countering inflammation after 3 d of heavy exertion in trained cyclists.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antioxidants / pharmacology*
  • C-Reactive Protein
  • Catechin / analogs & derivatives*
  • Catechin / pharmacology
  • Dietary Supplements
  • Docosahexaenoic Acids / pharmacology*
  • Double-Blind Method
  • Eicosapentaenoic Acid
  • Fatty Acids, Unsaturated / blood
  • Fatty Acids, Unsaturated / pharmacology*
  • Female
  • Granulocyte Colony-Stimulating Factor / blood
  • Humans
  • Interleukin-10 / blood
  • Interleukin-6 / blood
  • Male
  • Mitochondria / drug effects*
  • Oxidative Stress
  • PPAR gamma / drug effects
  • Quercetin / blood
  • Quercetin / pharmacology*
  • RNA, Messenger

Substances

  • Antioxidants
  • Fatty Acids, Unsaturated
  • Interleukin-6
  • PPAR gamma
  • RNA, Messenger
  • Interleukin-10
  • Granulocyte Colony-Stimulating Factor
  • Docosahexaenoic Acids
  • Catechin
  • C-Reactive Protein
  • Quercetin
  • Eicosapentaenoic Acid
  • epigallocatechin gallate